TrialClinical pharmacokinetics2025
Evaluation of Safety and Pharmacokinetics of DDCI-01, a Phosphodiesterase Type 5 Inhibitor, in Healthy Participants.
Qian Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it